Black checkmark with a sparkle and a curved line underneath on a white background.
Company

BIO KEY INTERNATIONAL INC

Ticker
BKYI
Sector
Industry
Report date
November 14, 2026
Valye AI Score

84

Very high visibility
Recent developments
Recent developments summary

Recent developments include the release of Q3 2026 earnings call transcripts and news reports highlighting a quarterly loss and revenue below expectations.

Recent developments:
  • BIO-key released its Q3 2026 earnings call transcript providing insights into operational and financial performance [N1].
  • The company reported a net loss and revenue below prior expectations for Q3 2026 [N2].
  • A Q2 2026 earnings call transcript was also published earlier in the year, offering additional context on company operations [N7].
Overview

BIO-key International Inc. is a technology company listed on the Nasdaq Capital Market under the ticker BKYI. The company completed a reverse stock split in April 2026, adjusting its shares outstanding to about 2 million. It operates across multiple regions including North America, Africa, EMESA, and Asia. The latest SEC filings provide detailed financial data through Q3 2026, showing the company maintains liquidity with a current ratio above 2. The company reported a net loss for the nine months ended September 30, 2026, with basic earnings per share of -$4.01. Recent earnings call transcripts and news reports provide additional context on its operational and financial performance.

Executive summary

Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. BIO-key International Inc. reported a net loss of approximately $886,000 for the nine months ended September 30, 2026, with liquidity ratios indicating a current ratio of 2.47 and a cash ratio of 1.04 as of that date [S2]. Recent news includes Q3 2026 earnings call transcripts and reports of a quarterly loss and revenue below prior expectations [N1][N2].

Scenarios for BKYI

Bull case model:

The company maintains liquidity with a current ratio of 2.47 and cash ratio above 1, indicating an ability to meet short-term obligations. Its operations across diverse regions may provide multiple revenue streams. Recent earnings calls offer transparency into business operations, which supports investor understanding of company strategy and execution.

Bear case model:

BIO-key reported a net loss for the nine months ended September 30, 2026, with negative earnings per share, indicating ongoing profitability challenges. Revenue for Q3 2026 was reported below prior expectations. The company’s relatively small share count post-reverse split may reflect limited market capitalization and liquidity. Lack of detailed disclosure on competitive positioning and product differentiation may limit visibility into long-term sustainability.

Moat:

BIO-key International Inc. operates in the biometric technology sector, which typically involves specialized intellectual property and technology solutions. The company's presence across multiple geographic regions suggests a diversified market approach. However, specific details on proprietary technology, customer contracts, or competitive advantages are not explicitly disclosed in the available filings and news.

Risks overview
Risks summary
The primary risks for BIO-key International Inc. relate to its ongoing net losses, revenue challenges, and limited disclosure on competitive advantages, which together impact the clarity of its long-term business sustainability.
Risks details:

• Profitability Risk: The company reported a net loss and negative earnings per share for the nine months ended September 30, 2026, indicating ongoing challenges in achieving profitability.
• Revenue Performance Risk: Recent news reports indicate Q3 2026 revenue lagged prior expectations, suggesting potential challenges in sales growth or market demand.
• Liquidity and Capital Structure Risk: While liquidity ratios are currently adequate, the company’s small cash balance and limited market capitalization post-reverse stock split may constrain financial flexibility.
• Limited Disclosure on Competitive Position: There is limited public information on the company’s proprietary technology, customer base, or competitive moat, which may affect visibility into future business sustainability.

FINAL FORECAST FOR BKYI

Final take one line
BIO-key International Inc. exhibits very high visibility with detailed recent financial disclosures and earnings commentary, though it faces profitability and revenue challenges.
Final take 12 to 24 month view

Business trends: The company continues to operate across multiple regions with ongoing revenue generation but reports net losses and revenue shortfalls.
Execution milestones: Recent quarterly earnings calls and SEC filings provide transparency into financial performance and liquidity status.
Key risks: Profitability challenges, revenue performance variability, limited disclosure on competitive positioning, and financial flexibility constraints.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

84
LLM visibility overview
LLM Visibility known facts
  • BIO-key International Inc. is a publicly traded company on the Nasdaq Capital Market under the ticker BKYI.
  • The company filed a 10-Q quarterly report for the period ended September 30, 2026, on November 13, 2026 [S2].
  • As of September 30, 2026, BIO-key had cash and cash equivalents of approximately $2.22 million and current assets totaling about $5.28 million, with current liabilities of approximately $2.14 million, resulting in a current ratio of 2.47 and a cash ratio of 1.04, indicating liquidity coverage [S2].
  • The company reported a net loss of approximately $886,000 for the nine months ended September 30, 2026, with basic earnings per share of -$4.01 for the same period [S2].
  • BIO-key completed a 1-for-10 reverse stock split effective April 30, 2026, adjusting its shares outstanding to approximately 2.04 million as of November 12, 2026 [S2].
  • The company operates in multiple geographic regions including North America, Africa, EMESA (Europe, Middle East, South America), and Asia as indicated in SEC filings [S2].
  • Recent earnings call transcripts for Q2 and Q3 2026 provide insights into the company's operational and financial performance [N1][N7].
  • News reports indicate BIO-key reported a Q3 2026 loss and revenue below prior expectations [N2].
Sources
Sources - Context summary

Generated 2026-11-14

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-06-12 | 10-K/A
  • S2 | 2026-11-13 | 10-Q
Sources - News headlines
  • N1 | 2026-11-13 | www.nasdaq.com | BIO-key (BKYI) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/bio-key-bkyi-q3-2026-earnings-call-transcript
  • N2 | 2026-11-13 | www.nasdaq.com | BIO-key International Inc. (BKYI) Reports Q3 Loss, Lags Revenue Estimates | https://www.nasdaq.com/articles/bio-key-international-inc-bkyi-reports-q3-loss-lags-revenue-estimates
  • N3 | 2026-11-12 | www.nasdaq.com | Dragonfly Energy Holdings Corp. (DFLI) Reports Q3 Loss, Misses Revenue Estimates | https://www.nasdaq.com/articles/dragonfly-energy-holdings-corp-dfli-reports-q3-loss-misses-revenue-estimates
  • N4 | 2026-11-05 | www.nasdaq.com | Rockwell Automation (ROK) Surpasses Q4 Earnings Estimates | https://www.nasdaq.com/articles/rockwell-automation-rok-surpasses-q4-earnings-estimates
  • N5 | 2026-11-04 | www.nasdaq.com | Power Integrations (POWI) Q3 Earnings Surpass Estimates | https://www.nasdaq.com/articles/power-integrations-powi-q3-earnings-surpass-estimates
  • N6 | 2026-10-28 | www.nasdaq.com | Hayward Holdings, Inc. (HAYW) Q3 Earnings and Revenues Beat Estimates | https://www.nasdaq.com/articles/hayward-holdings-inc-hayw-q3-earnings-and-revenues-beat-estimates
  • N7 | 2026-08-21 | www.nasdaq.com | BIO-key (BKYI) Q2 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/bio-key-bkyi-q2-2026-earnings-call-transcript
  • N8 | 2026-06-22 | www.nasdaq.com | Stocks Erase Early Gains as Alphabet and Software Companies Fall | https://www.nasdaq.com/articles/stocks-erase-early-gains-alphabet-and-software-companies-fall
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine